Atom | Mitochondrial-associated Mechanisms of Neuropathological and Immunodeficient Aging in the Context of HIV and SUD (R21 Clinical Trials Not Allowed)

Funder: National Institutes of Health

Due Dates: February 10, 2025 (Letter of Intent & Open Date) | March 10, 2025 (AIDS applications) | March 10, 2026 (AIDS applications)

Funding Amounts: Up to $275,000 direct costs over 2 years (no more than $200,000 in any single year); 3–6 awards anticipated; total program funding $3M (FY26)

Summary: Supports exploratory research on mitochondrial mechanisms in aging, HIV infection, and substance use, aiming to inform targeted therapies for people aging with HIV and addiction.

Key Information: Clinical trials are not allowed; applications must address the intersection of HIV and misused substances (not alcohol alone).

Mitochondrial-associated Mechanisms of Neuropathological and Immunodeficient Aging in the Context of HIV and SUD (R21 Clinical Trials Not Allowed)

Sign in to see full grant listing